Published November 30, 2024 | Version v1

Neurological complications in Burkitt lymphoma – clinical case

  • 1. ROR icon National Institute of Emergency Medicine "Pirogov"

Description

Involvement of the nervous system by malignant diseases is often observed, especially in patients with lymphoproliferative processes. The appearance of neurological symptoms in a patient with an underlying neoplastic process requires the exclusion of metastases in the nervous system. Burkitt's lymphoma belongs to the group of non-Hodgkin's lymphomas. The risk of involvement of the nervous system is high, and in a number of cases preventive intrathecal chemotherapy is carried out in the early stages after diagnosis. Unfortunately, conducting such prophylaxis does not give results in all patients, and can also cause neurological complications. In the present publication, we present a case of a 29-year-old patient who was recently diagnosed with Burkitt's lymphoma. Upon admission, the patient complained of visual and speech disorders, which were of a short-term nature. From the examination, a lumbar vertebral syndrome was objectified, which progressed acutely in the next days to the development of lower flaccid paraparesis. In the context of the underlying disease and assuming the courses of radiotherapy and chemotherapy undergone, a definitive diagnosis required the exclusion of a number of conditions and multispecialty collaboration.

Abstract (Bulgarian)

Ангажирането на нервната система от злокачествени заболявания се наблюдава често особено при пациентите с лимфопро лиферативни процеси. Появата на неврологична симп томатика при пациент с подлежащ неопластичен процес налага изключване на метастази в нервната система. Лимфомът на Бъркит принадлежи към групата на неходжкиновите лимфоми, рискът от ангажиране на нервната система е висок и в реди ца случаи се провежда превантивна интратекална химиотерапия още в ранните етапи след поставянето на диагнозата. Провеждането на подобна профилактика за съжаление не дава резултат при всички пациенти, а също така създава предпоставки за развитие на неврологични усложнения. В настоящата публикация представяме клиничен случай на пациент на 29 години, който наскоро бива диагностициран с лимфом на Бъркит. При постъпването пациентът е с оплаквания от зрителни и го- ворни нарушения, които са с краткотраен характер. От прегледа се обективизира допълнително лумбален вертебрален синдром, който прогресира остро в следващите дни до развитието на долна вяла парапареза. В контекста на основното заболяване и претърпените лечебни курсове с лъчетерапия и химиотерапевтици поставянето на окончателна диагноза наложи изключване на редица състояния и тясна колаборация между различни специалности.

Files

bn-v25-n2-5.pdf

Files (1.2 MB)

Name Size
md5:db0701d90253b11abd2ad3bb56408954
1.2 MB Preview Download

Additional details

Identifiers

Dates

Issued
2024-11-30

References

  • 1. Bönig, L., Möhn, N., Ahlbrecht, J., Wurster, U., Raab, P., Puppe, W., Sühs, KW., Stangel M, Skripuletz, T., Schwenkenbecher, P., Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics. Front Neurol. 2019 Aug 20, 10, 839.
  • 2. Byrnes, D.M., Vargas, F., Dermarkarian, C., Kahn, R., Kwon, D., Hurley, J., Schatz JH. Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive Patients. J. Oncol. 2019 May 2, 2019, 4047617.
  • 3. Camilo, G.B., Machado, D.C. de Oliveira CE., Lacerda, Lda S., de Oliveira, R.V., Silva, Mde F., Lopes, A.J. Burkitt lymphoma with initial clinical presentation due to infiltration of the central nervous system and eye orbits. Am. J. Case Rep. 2014 Sep 22, 15, 404-410.
  • 4. Cachia, D., Kamiya-Matsuoka, C., Pinnix, C.C., Chi, L., Kantarjian, H.M., Cortes, J.E., Daver, N., Woodman, K. Myelopathy following intrathecal chemotherapy in adults: a single institution experience. J Neurooncol. 2015 Apr, 122, 2, 391-398.
  • 5. Dukenik, D.B., Soong, D., Li, W., Madarang, E., Watts, J., Taylor, J. Methotrexate-Induced Subacute Combined Degeneration in Acute Lymphoblastic Leukemia with CNS Relapse May Be Reversible. Hemato. 2023, 4, 4, 311-312.
  • 6. Erik, Z., Andrés Felipe, Linares., Oscar, Iván Reyes., et al. Central Nervous System Involvement in Burkitt Lymphoma: A Case Report and Review of Literature. Authorea. May 26, 2022.
  • 7. Hyun, S. K., Kyoung-Keun, Kim., Ok Joon Kim, MD. A Case of Diffuse Large B-Cell Lymphoma Presenting as Transverse Myelopathy. J Neurocrit Care 2008, 1, 2, 177-180.
  • 8. Lakshmi, N., Tracy, T. Batchelor. How I treat neurologic complications in patients with lymphoid cancer. Blood, Volume 139, Issue 10, 2022, Pages 1469-1478.
  • 9. Miyoshi, T., Kondo, T., Nishikori, M., Kitawaki, T., Kobayashi, K., Fujimoto, M., Yoshinaga, N., Oka, S., Asagoe, K., Imashuku, S., Takaori-Kondo, A. Methotrexate-induced subacute myelopathy: a serious but treatable complication. J. Clin. Exp. Hematop. 2023, 63, 4, 251-256.
  • 10. Namita, S., Giriraj, S.G., Madhvi, T., Rajnish, S., Pawan Kumar, Sanjeev, Saw., Anupam, M., Rajender, P. Burkitt's lymphoma with leptomeningeal metastasis: Demonstration by FDG-PET and MRI. European Journal of Radiology Extra, Volume 69, Issue 1, January 2009, Pages e5-e8.
  • 11. Quentin-Gondard A. et al. Spinal cord involvement in a Burkitt lymphoma patient. Cancer Rep. Rev. 1, 2017.
  • 12. Ying, Pan., Chunhauai, Wang., Huiping, Wang., Qianshan, Tao., Shudao, Xiong., and Zhimin Z.: Transverse myelopathy occurring with intrathecal administration of methotrexate and cytarabine chemotherapy: A case report. Oncology Letters vol. 11, 2016, 4066-4068.
  • 13. Zayac, AS., Evens, AM., Danilov, A., Smith, SD., Jagadeesh, D., et al. Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study. Haematologica. 2021 Jul 1, 106, 7, 1932-1942.